<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Закирова, А.Н.</author>
     <author>Фаткуллина, Е.З.</author>
     <author>Закирова, Н.Э.</author>
     <author>Жамалов, Л.М.</author>
    </authors>
   </contributors>
   <titles>
    <title>ИНСУЛИНОПОДОБНЫЙ ФАКТОР РОСТА-1 И РЕМОДЕЛИРОВАНИЕ МИОКАРДА У ПАЦИЕНТОК С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ И МЕТАБОЛИЧЕСКИМ СИНДРОМОМ</title>
   </titles>
   <dates>
    <year>2015</year>
    <pub-dates>
     <date>2018-02-28</date>
    </pub-dates>
   </dates>
   <abstract>Aim. To establish the role of insulin-like growth factor-1 (IGF-1) in left ventricular remodeling in female patients with arterial hypertension (HT) and metabolic syndrome (MS)&#13;
with different stages of obesity.&#13;
Material and methods. The study included 108 women with HT and MS, who were divided into 3 groups according to the stage of obesity, and 28 healthy women. The level of&#13;
IGF-1, hemodynamic status and types of left ventricular remodeling were assessed.&#13;
Results. Concentric remodeling and IGF-1 elevation (165.3±12.03 ng/ml) prevailed in patients with HT and first stage of obesity. Concentric hypertrophy of left ventricle and&#13;
normal level of IGF-1 (118.5±10.05 ng/ml) were established in patients with second stage of obesity. Lack of IGF-1 (96.4±8.11 ng / ml) was determined in women with third&#13;
stage of obesity and eccentric hypertrophy. Correlation analysis in patients with 2-3 stages of obesity showed significant associations between the level of IGF-1 and hemodynamic&#13;
parameters.&#13;
Conclusion. Changes in the level of IGF-1 in patients with AH and MS correlate with types of remodeling and stage of obesity</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/677</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/768</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
